Prevention of muscle fatigue in healthy individuals
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female undergraduate students aged 18 years or older, who are right-handed and enrolled at Saitama Prefectural University 2. No history of orthopedic diseases in the upper extremities 3. No known allergy to any component of the topical agents used in this study 4. No sensory or motor disorder in the upper extremities 5. Received sufficient explanation of the purpose and content of this study and provided written informed consent 6. No physical functional problems in daily life, and judged to be able to participate safely in the study 7. Able to expose the skin from fingertips to upper arms for topical agent application 8. No known allergy to any component of the topical agents used in this study
Exclusion criteria
Exclusion criteria: 1. Those with metal allergy 2. Those with inflammation, trauma, or skin diseases (atopic dermatitis, eczema, etc.) at the application site 3. Those with heart disease, neurological disease, or other serious underlying conditions 4. Those with a history of hypersensitivity reactions to topical agents (aspirin preparations: ASA), adverse effects common to NSAIDs (non-steroidal anti-inflammatory drugs), or aspirin-induced asthma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle fatigue (changes in median frequency of surface electromyography) and subjective fatigue and pain (Visual Analogue Scale: VAS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin surface blood flow, electromyographic discharge (%MVE), subjective evaluation scores at each measurement time point | — |
Countries
Japan
Contacts
Saitama Prefectural University Department of Occupational Therapy/Graduate School of Health and Social Services